← Back to Clinical Trials
Recruiting Phase 1, Phase 2 NCT06431165
Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.
Trial Parameters
Condition Perioperative Pain Management
Sponsor Cairo University
Study Type INTERVENTIONAL
Phase Phase 1, Phase 2
Enrollment 69
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-03-15
Completion 2025-03
Interventions
Lidocaine IV
Brief Summary
This study aimed To investigate the effects of different doses of Intraoperative intravenous lidocaine infusion on intraoperative opioid consumption, perioperative pain control and incidence of postoperative chronic pain.
Eligibility Criteria
Inclusion Criteria: * Patients age between 18 and 65. * Patients with ASA I and II status. * Patients undergoing open laparotomy surgeries (including open cholecystectomies). Exclusion Criteria: * Patients unable to comprehend the informed consent. * Patients on long term pre-operative opioid regimens. * Patients with impairment in hepatic or renal functions. * Patients who are planned to receive any form of regional block for the surgery.